Human Papillomavirus Testing Market exhibiting CAGR of 12.5% from 2023 to 2032, owing to increasing number of cervical cancer cases & growing aging population | insightSLICE
The global Human Papillomavirus Testing market size was estimated to be US$ 850 million in 2021 and is expected grow at a CAGR of 12.5% between 2023 to 2032.
HPV also known as human papillomavirus is a group of 150 related viruses that can infect the human squamous epithelial cells. They can only infect and survive in these cell types causing skin conditions like warts and non-cancerous tumors in the infected region.
Some types of HPV are also capable of infecting the mucosal surface of the cervix, vulva, and penis and thereby causing cancer in these organs. The later types of HPV are one of the major causes of cervical cancer in the global female population.
Access the sample report: https://www.insightslice.com/request-sample/1330
As HPV infection in the cervix is generally associated with a high prevalence of cervical cancer, early diagnosis of the HPV infection can help prevent the progression and development of cancer. Pap tests that detect abnormal cell growth in the cervix are usually suggested along with HPV tests to identify the involvement of this virus and therefore target it directly.
Usually, women with the presence of abnormal cells identified through Pap tests are considered high-risk patients and therefore are the largest consumers of human papillomavirus testing services.
The low-risk group consists of individuals with cervical infections, and people having recurrent or persistent HPV infections in other parts and they hold a relatively small share of the HPV testing market.
The key players of the Global Human Papillomavirus Testing Market are:
Prominent players like Abbott Labs., Biomedical Diagnostics Inc., bioMerieux, Bio-Rad, Epigenomics, Gen-Probe, OncoLab, Radient Pharmaceuticals, Roche, Sequenom, Siemens Healthcare, and Qiagen, have a major presence in the global HPV testing market.
Competitive market strategies are being employed by these companies to ensure growth and sales which will positively help the HPV testing market at large.
Read more about the report inclusions: https://www.insightslice.com/human-papillomavirus-testing-market
Driving factors for the growth of Global Human Papillomavirus Testing Market
Increasing awareness of the link between cervical cancer and HPV infection has caused a big increase in demand for these tests in clinical and diagnostic settings. Rising prevalence has resulted in a gradual rise of high-risk patients which drives the growth of the global human papillomavirus testing market.
Large old female populations are also prone to cancer caused by HPV and thus may take such tests routinely to check the infection. Simultaneously, increased comorbidities and co-infection risks have propelled the growth of the diagnostics market which will also enable the growth of the HPV testing market.
The rising mortality of cervical cancer patients also plays a huge part in the faster adoption of human papillomavirus testing services.
New technologies like automated testing protocols, reliable results, reduced cost, and increased scale of this economy along with a subsequent rise in cancer patient care will also contribute to the cervical cancer diagnostics and global human papillomavirus testing market.
Compliance with new guidelines and better development strategies have also helped achieve quick product approvals and enhanced individual market positions.
Global Human Papillomavirus Testing Market Key Segments:
By Product types
- Consumables
- Types of equipment
By End User
- Diagnostic Centers
- Hospitals
- Clinics
By Geography
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
The leading market segments of Global Human Papillomavirus Testing Market
Molecular diagnostics tools are used primarily for human papillomavirus testing and therefore are the largest market across the globe. Simple and precise detection of several types of HPV, and the inability of culturing methods to grow HPV in the lab have significantly increased the use of molecular methods for HPV testing.
Target amplification and probe amplification can result in the enhancement of signals and better detection even if the infection is in its nascent stages. Advanced screening tests and their increased specificity enables rapid detection of disease and therefore their adoption has been increased everywhere.
The benefits provided by molecular diagnostic methods are presumed to lead to the growth in human papillomavirus testing and also enable quicker adoption of these services globally.
Furthermore, cytology-based testing services are significantly impacted due to their economic constraints.
Several developing and poor nations are expected to utilize molecular HPV testing more frequently than that cytological testing services Cytology detection also requires better infrastructure and highly trained professionals to handle the cells aseptically.
These complications and a moderate range of sensitivity compared to direct HPV testing have resulted in increased use of human papillomavirus testing in the world.
Related reports:
Global Peripheral Vascular Devices Market: https://www.insightslice.com/peripheral-vascular-devices-market
Global Specialty Pharmaceuticals Market: https://www.insightslice.com/specialty-pharmaceuticals-market
Regional performance of Human Papillomavirus Testing Market
The North America market leads the growth of the HPV testing market and will continue to do so during the forecast period.
Major factors contributing to this growth are the increased prevalence of cervical cancer in the USA and Canada, along with a large geriatric female population. Growing preference for early diagnosis can also be considered a significant factor in the growth of HPV testing demand across this region.
The Asia-Pacific region will also show positive growth for the human papillomavirus testing market as the increasing population drives the growth. The high prevalence of sexually transmitted diseases also helps the growth of HPV testing as clinicians suggest varied tests to patients.
Growth limiting factors
Primary screening tests for cancer-associated factors are less sensitive to HPV and can cause false negatives. Therefore, direct HPV testing is seeing increased adoption by clinicians because of its accuracy.
Moreover, the HPV-induced cervical cancer risk for females vaccinated with HPV vaccines largely remains unchanged. Thus, the demand for human papillomavirus testing in vaccinated females also spurs the growth of this testing.
Proceed to purchase: https://www.insightslice.com/buy-now/1330
insightSLICE is a market intelligence and strategy consulting company. The company provides tailor-made and off the shelf market research studies. The prime focus of the company is on strategy consulting to provide end-to-end solutions. For more details, please contact our research and consulting team at info@insightslice.com.
Contact us:
Alex R
+1 707 736 6633
Editor Details
-
Company:
- insightSLICE
- Website:
